Next Article in Journal
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study
Next Article in Special Issue
Impact of Nutritional Status on Neutrophil-to-Lymphocyte Ratio as a Predictor of Efficacy and Adverse Events of Immune Check-Point Inhibitors
Previous Article in Journal
HER2 and PD-L1 Expression in Gastric and Gastroesophageal Junction Cancer: Insights for Combinatorial Targeting Approaches
Previous Article in Special Issue
Takotsubo Cardiomyopathy in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Summary of Included Cases
 
 
Article

Article Versions Notes

Cancers 2024, 16(6), 1226; https://doi.org/10.3390/cancers16061226
Action Date Notes Link
article pdf uploaded. 20 March 2024 16:12 CET Version of Record https://www.mdpi.com/2072-6694/16/6/1226/pdf-vor
article supplementary file uploaded. 20 March 2024 16:12 CET - https://www.mdpi.com/2072-6694/16/6/1226#supplementary
article xml file uploaded 21 March 2024 04:50 CET Original file -
article xml uploaded. 21 March 2024 04:50 CET Update https://www.mdpi.com/2072-6694/16/6/1226/xml
article pdf uploaded. 21 March 2024 04:50 CET Updated version of record https://www.mdpi.com/2072-6694/16/6/1226/pdf
article html file updated 21 March 2024 04:52 CET Original file https://www.mdpi.com/2072-6694/16/6/1226/html
Back to TopTop